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Readmission after stroke: Recurrence or infection?Stroke is a major cause of morbidity and mortality world-
wide in both developed and undeveloped countries. In 2012, it
was the third leading cause of death and the leading cause of
disability in elderly individuals in Taiwan.1 Stroke constitutes
a major public health problem that poses a tremendous soci-
oeconomic burden on society. About 70% of acute stroke
events result in hospitalization.2 The duration of hospital-
ization is longer and rates of readmission, medical comor-
bidities, and expenditures are higher for stroke patients than
for patients with other chronic illnesses.2,3
After discharge following acute hospitalization, stroke
survivors usually experience persistent neurological symptoms
that require ongoing medical attention. Additionally, they are
at a high risk for new illness (including recurrent stroke),
aggravation of known disease, and functional decline, all of
which ultimately lead to a high risk of rehospitalization.
Readmission rates show the ongoing challenges that stroke
survivors face: 18e28% are readmitted within the first 3
months,4,5 26e44% within 6 months,6 and 50% within 1
year;4,5,7 less than 15% of survivors remain admission-free for
5 years.7 Stroke is the second leading cause of hospital
admission in elderly individuals.8 Age, stroke severity, recur-
rent vascular events (e.g., stroke, cardiovascular events), other
comorbidities (e.g., diabetes, hypertension), and infection
were the most common reasons for readmission.
Nonvascular complications are common reasons for reho-
spitalization in stroke survivors. Infection (e.g., pneumonia or
respiratory distress, urinary tract infection) is among the most
common reasons for readmission, particularly during the early
period after discharge.7,9 These complications may be related
to neurological sequelae, such as dysphagia, sphincter dys-
function, and limited motor function, as well as poor quality of
care and nutritional status after discharge. Dysphagia is
especially common among stroke patients with pneumonia,
and it is a leading cause of nonvascular death after stroke in
acute and chronic settings.7 Although dysphagia is frequently
encountered in stroke patients, it is not an independent pre-
dictor for stroke survival.10 However, other factors such as
advanced age, stroke severity, and other comorbidities might
play important roles in predicting stroke outcome.
The importance of recurrent stroke is well recognized in
terms of clinical outcome and high healthcare cost.11 In
addition, recurrent stroke remains a leading cause for read-
mission after stroke.7 Many clinical guidelines and several1726-4901/$ - see front matter Copyright  2013 Elsevier Taiwan LLC and the C
http://dx.doi.org/10.1016/j.jcma.2013.08.004medical societies, such as the Taiwan Stroke Society, have
recommended therapies, such as the use of antithrombotic
agents, to prevent recurrent ischemic stroke and thereby
reduce the rate of readmission. However, the percentage of
patients taking antiplatelet agents after stroke decreases with
time,12 which highlights the importance of bridging the often-
unrecognized gap between clinical guidelines and clinical
practice in poststroke care.9
Not surprisingly, advanced age is one of the strongest
predictive factors for poststroke outcome.9,10 Other factors
affecting the risk of rehospitalization include atrial fibrillation,
myocardial infarction, and other cardiovascular events. In one
study, the number of readmissions for acute myocardial
infarction was comparable to that for stroke,7 demonstrating
the common vascular nature of cardiovascular and cere-
brovascular diseases.
The presence of medical comorbidities is also an important
risk factor for rehospitalization. Diabetes is a well-known risk
factor for poor prognosis of long-term survival.10 Diabetes
and impaired cognition were independent predictors of sur-
vival in elderly stroke patients. The role of hypertension in
stroke survivors is controversial,10 although it is a powerful
independent risk factor for cardiovascular diseases. The dif-
ficulty of defining this role may be due to the fact that patients
may receive appropriate treatment for hypertension during
follow-up.13
In the current era of globally escalating stroke care burden,
the cost effectiveness of specialized stroke services must be
evaluated in each healthcare system. In 2010, 122,723 of 23
million inhabitants were hospitalized because of cere-
brovascular disease (CVD), constituting 6.7% of all hospital
admissions in Taiwan.14 In that year, 10,134 individuals died
from CVD, which is equivalent to a crude death rate of 43.8/
100,000 persons and accounts for 7.0% of all deaths. The
healthcare cost associated with CVD was US$ 401 million,
which constituted 2.76% of the total annual healthcare
expenditure throughout the entire National Health Insurance
program in Taiwan.
In this issue of the Journal of the Chinese Medical Asso-
ciation, Lee et al15 report on reasons for readmission, mor-
tality rate, and medical cost during the first year after acute
stroke. In an analysis of the National Health Insurance
Research Database, the authors found a high rate (w50%)
of readmission during the first year after acute stroke,hinese Medical Association. All rights reserved.
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orrhagic stroke (HS; subarachnoid or intracerebral hemor-
rhage) than for ischemic stroke (IS). Vascular (recurrent stroke
and heart/circulatory diseases) and nonvascular (late effect of
previous stroke, respiratory disease/infection, and diseases of
the digestive system) causes were major reasons for read-
mission. Advanced age, hemorrhagic stroke, and greater
number of comorbidities were predictors of poor outcome.
Initial hospitalization constituted nearly half (44%) of the first-
year medical cost (FYMC). Of note, 29% of the FYMC was
due to readmission. Patients with HS had higher FYMCs than
did those with IS. This study confirmed the findings that more
life years were lost and greater number of comorbidities in HS
than in IS patients, which was explained by greater FYMCs
for HS patients.
In conclusion, stroke survivors have tremendous neuro-
logical and nonneurological sequelae. The use of up-to-date
databases is warranted to examine secular trends in stroke
care and explore underlying determinants for the development
of effective initiatives to improve stroke outcomes. Further
studies incorporating functional status or utility measurement
data from stroke survivors, collected from clinical trials or
stroke registries, in cost-utility analyses of stroke management
are urgently needed.Acknowledgments
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